title: Active Toll-like receptor-7 triggering of chronic lymphocytic leukemia B-cells by imiquimod.
authors.forename: Min
authors.initials: M
authors.lastname: Chen
authors.forename: Marcelo de Carvalho
authors.initials: Mde C
authors.lastname: Bittencourt
authors.forename: Pierre
authors.initials: P
authors.lastname: Feugier
authors.forename: Gilbert C
authors.initials: GC
authors.lastname: Faure
authors.forename: Marie C
authors.initials: MC
authors.lastname: Béné
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000634:Aminoquinolines / Q000494:pharmacology*; D018941:Antigens, CD19 / Q000378:metabolism; D000970:Antineoplastic Agents / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects*; D018956:CD5 Antigens / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D000077271:Imiquimod; D020287:In Situ Nick-End Labeling; D015850:Interleukin-6 / Q000378:metabolism; D016209:Interleukin-8 / Q000378:metabolism; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D051199:Toll-Like Receptor 7 / Q000819:agonists / Q000378:metabolism*; D014407:Tumor Cells, Cultured
chemical_list: D000634:Aminoquinolines; D018941:Antigens, CD19; D000970:Antineoplastic Agents; D018956:CD5 Antigens; D016207:Cytokines; D015850:Interleukin-6; D016209:Interleukin-8; C495348:TLR7 protein, human; D051199:Toll-Like Receptor 7; D000077271:Imiquimod